These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6852094)

  • 41. Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.
    Bolaños FJ; Schechter LE; Miquel MC; Emerit MB; Rumigny JF; Hamon M; Gozlan H
    Biochem Pharmacol; 1990 Oct; 40(7):1541-50. PubMed ID: 2222509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Allosteric effect of serotonin and mianserin on the kinetics of specific [3H]-ligand binding to adrenergic and muscarinic receptors in the rat cerebral cortex membranes].
    Manukhin BN; Nesterova LA
    Izv Akad Nauk Ser Biol; 2015; (2):169-79. PubMed ID: 26021159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
    Kidd FJ; Levy JC; Nielsen M; Hamon M; Gozlan H
    Eur J Pharmacol; 1993 Sep; 247(1):45-56. PubMed ID: 8258360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 5HT2 binding sites after mianserin: comparison of loss of sites and brain levels of drug.
    Sanders-Bush E; Breeding M; Roznoski M
    Eur J Pharmacol; 1987 Jan; 133(2):199-204. PubMed ID: 3816985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
    Ge J; Barnes JM; Towers P; Barnes NM
    Eur J Pharmacol; 1997 Aug; 332(3):307-12. PubMed ID: 9300265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estradiol-induced increase of specific [3H]ketanserin binding sites on rat uterine membranes.
    Ichida S; Hayashi T; Kita T; Murakami T
    Eur J Pharmacol; 1985 Feb; 108(3):257-64. PubMed ID: 3157585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of cholate-solubilized dopamine receptors from human, dog and rat brain.
    Wouters W; van Dun J; Laduron PM
    Biochem Pharmacol; 1984 Dec; 33(24):4039-44. PubMed ID: 6508850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
    Pranzatelli MR; Murthy JN; Pluchino RS
    J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spermine modulation of specific [3H]-gabapentin binding to the detergent-solubilized porcine cerebral cortex alpha 2 delta calcium channel subunit.
    Dissanayake VU; Gee NS; Brown JP; Woodruff GN
    Br J Pharmacol; 1997 Mar; 120(5):833-40. PubMed ID: 9138689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distribution of histaminergic, muscarinic and serotonergic binding sites in cat spinal cord with emphasis on the region surrounding the central canal.
    Seybold VS
    Brain Res; 1985 Sep; 342(2):291-6. PubMed ID: 4041830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mianserin kinetics in depressed patients.
    Hrdina PD; Lapierre YD; McIntosh B; Oyewumi LK
    Clin Pharmacol Ther; 1983 Jun; 33(6):757-62. PubMed ID: 6851406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of binding sites for [3H]spiroperidol.
    Luedtke RR; Molinoff PB
    Biochem Pharmacol; 1987 Oct; 36(19):3255-64. PubMed ID: 2959288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mianserin metabolites.
    Altamura AC; Melorio T
    Br J Clin Pharmacol; 1983 Aug; 16(2):201-3. PubMed ID: 6615696
    [No Abstract]   [Full Text] [Related]  

  • 54. Increased cortical serotonin-2 (5-HT-2) receptors in the iminodipropionitrile (IDPN)-model of persistent dyskinesia in the rat.
    Cadet JL; Rothman RB
    Neuropeptides; 1987; 10(2):175-80. PubMed ID: 3683772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of age on mianserin pharmacokinetics.
    Altamura AC; Melorio T; Invernizzi G; Gomeni R
    Psychopharmacology (Berl); 1982; 78(4):380-2. PubMed ID: 6818603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solubilization and characterization of moderate and high affinity histamine binding sites on human blood mononuclear cells.
    Warlow RS; Bernard CC
    Mol Immunol; 1987 Jan; 24(1):27-37. PubMed ID: 3614205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of the membranous antiestrogen binding protein: I. Partial purification of the protein in its active state.
    Chailleux C; Poirot M; Mesange F; Bayard F; Faye JC
    J Recept Res; 1994 Jan; 14(1):23-35. PubMed ID: 8158580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the membranous antiestrogen binding protein: II. Purification to homogeneity.
    Poirot M; Chailleux C; Mesange F; Bayard F; Faye JC
    J Recept Res; 1994 Jan; 14(1):37-46. PubMed ID: 8158581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and biological properties of thiophene ring analogues of mianserin.
    Watthey JW; Gavin T; Desai M; Finn BM; Rodebaugh RK; Patt SL
    J Med Chem; 1983 Aug; 26(8):1116-22. PubMed ID: 6192241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purification of a cell growth inhibitor from bovine cerebral cortex cells.
    Johnson TC; Kinders RJ; Sharifi BG
    Life Sci; 1985 Sep; 37(12):1117-23. PubMed ID: 4041001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.